Teva Pharmaceutical Industries (TEVA) Other financing activities: 2009-2025
Historic Other financing activities for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Sep 2025 value amounting to -$2.0 million.
- Teva Pharmaceutical Industries' Other financing activities was N/A to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year change of. This contributed to the annual value of -$8.0 million for FY2024, which is 96.23% up from last year.
- Teva Pharmaceutical Industries' Other financing activities amounted to -$2.0 million in Q3 2025, which was down 300.00% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Other financing activities registered a high of $11.0 million during Q4 2024, and its lowest value of -$76.0 million during Q3 2023.
- In the last 3 years, Teva Pharmaceutical Industries' Other financing activities had a median value of -$7.0 million in 2023 and averaged -$21.8 million.
- Data for Teva Pharmaceutical Industries' Other financing activities shows a peak YoY increase of 200.00% (in 2022) and a maximum YoY decrease of 4,100.00% (in 2022) over the last 5 years.
- Over the past 5 years, Teva Pharmaceutical Industries' Other financing activities (Quarterly) stood at -$1.0 million in 2021, then plummeted by 200.00% to -$3.0 million in 2022, then tumbled by 2,433.33% to -$76.0 million in 2023, then soared by 114.47% to $11.0 million in 2024, then surged by 110.00% to -$2.0 million in 2025.
- Its Other financing activities was -$2.0 million in Q3 2025, compared to $1.0 million in Q2 2025 and $3.0 million in Q1 2025.